PARP(ポリADPリボースポリメラーゼ)阻害剤のグローバル市場2024-2028:小売薬局、病院薬局、オンライン薬局

【英語タイトル】Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market 2024-2028

Technavioが出版した調査資料(IRTNTR43323-23)・商品コード:IRTNTR43323-23
・発行会社(調査会社):Technavio
・発行日:2023年10月12日
・ページ数:約120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:北米、ヨーロッパ、アジア、その他地域
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

PARP(ポリADPリボースポリメラーゼ)阻害剤の世界市場 2024〜2028年PARP(ポリADPリボースポリメラーゼ)阻害剤市場は、2023年から2028年にかけて5億5599万米ドルの成長が予測され、予測期間中のCAGRは13.25%で加速すると予測されています。当レポートでは、PARP(ポリADPリボースポリメラーゼ)阻害剤市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析も掲載しています。
当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供します。PARP阻害剤の適用拡大、さまざまな癌の適応症に対する投与の容易さ、患者支援プログラムの増加などが市場を牽引しています。

テクナビオのPARP(ポリADPリボースポリメラーゼ)阻害剤市場は以下のように区分されます。
流通チャネル別
- 小売薬局
- 病院薬局
- オンライン薬局

エンドユーザー別
- 卵巣がん
- 乳がん
- その他

地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)

本調査では、今後数年間のPARP(ポリADPリボースポリメラーゼ)阻害剤市場の成長を促進する主な理由の一つとして、現在進行中の広範な研究を挙げています。また、癌の有病率の増加やヒト遺伝子の新たな研究分野は、市場の大きな需要につながるでしょう。

この調査レポートは、PARP(ポリADPリボースポリメラーゼ)阻害剤市場を調査・分析した結果をまとめたものです。
- PARP(ポリADPリボースポリメラーゼ)阻害剤市場規模
- PARP(ポリADPリボースポリメラーゼ)阻害剤市場の予測
- Parp(ポリADPリボースポリメラーゼ)阻害剤市場の産業分析

本レポートでは、PARP(ポリADPリボースポリメラーゼ)阻害剤市場の主要ベンダーとして、AbbVie Inc., Allarity Therapeutics Inc., Artios Pharma, AstraZeneca Plc, Bayer AG, BeiGene Ltd., Daiichi Sankyo Co. Ltd., Everest Pharmaceuticals Ltd., GlaxoSmithKline Plc, IMPACT Therapeutics, Jeil Pharmaceuticals Co. Ltd., Jiangsu Hengrui Pharmaceuticals Co. Ltd., Johnson and Johnson, Karyopharm Therapeutics Inc., Merck and Co. Inc., Ono Pharmaceutical Co. Ltd., Pfizer Inc., Repare Therapeutics Inc., Teva Pharmaceutical Industries Ltd., and Zai Lab Ltd.などを分析しています。また、parp(ポリADPリボースポリメラーゼ)阻害剤市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。当レポートでは、主要ベンダーの分析に加え、包括的な市場とベンダーの状況を掲載しています。
当調査会社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細な姿を提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

1 エグゼクティブサマリー
2 市場状況
3 市場規模
4 過去の市場規模
5 ファイブフォース分析
6 PARP(ポリADPリボースポリメラーゼ)阻害剤の世界市場:流通チャネル別市場分析
7 PARP(ポリADPリボースポリメラーゼ)阻害剤の世界市場:エンドユーザー別市場分析
8 顧客状況
9 地域別状況
10 推進要因・課題・動向
11 企業状況
12 企業分析
13 付録

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global PARP (poly ADP-ribose polymerase) inhibitors market 2018 – 2022
o Exhibit 18: Historic Market Size – Data Table on global parp (poly adp-ribose polymerase) inhibitors market 2018 – 2022 ($ million)
o 4.2 Distribution Channel Segment Analysis 2018 – 2022
o Exhibit 19: Historic Market Size – Distribution Channel Segment 2018 – 2022 ($ million)
o 4.3 End-user Segment Analysis 2018 – 2022
o Exhibit 20: Historic Market Size – End-user Segment 2018 – 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 – 2022
o Exhibit 21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
o 4.5 Country Segment Analysis 2018 – 2022
o Exhibit 22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2023 and 2028
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel – Market share 2023-2028 (%)
o Exhibit 31: Data Table on Distribution Channel – Market share 2023-2028 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Retail pharmacies – Market size and forecast 2023-2028
o Exhibit 34: Chart on Retail pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Retail pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Retail pharmacies – Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Retail pharmacies – Year-over-year growth 2023-2028 (%)
o 6.4 Hospital pharmacies – Market size and forecast 2023-2028
o Exhibit 38: Chart on Hospital pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Hospital pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Hospital pharmacies – Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Hospital pharmacies – Year-over-year growth 2023-2028 (%)
o 6.5 Online pharmacies – Market size and forecast 2023-2028
o Exhibit 42: Chart on Online pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 43: Data Table on Online pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 44: Chart on Online pharmacies – Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Online pharmacies – Year-over-year growth 2023-2028 (%)
o 6.6 Market opportunity by Distribution Channel
o Exhibit 46: Market opportunity by Distribution Channel ($ million)
o Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ million)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 48: Chart on End-user – Market share 2023-2028 (%)
o Exhibit 49: Data Table on End-user – Market share 2023-2028 (%)
o 7.2 Comparison by End-user
o Exhibit 50: Chart on Comparison by End-user
o Exhibit 51: Data Table on Comparison by End-user
o 7.3 Ovarian cancer – Market size and forecast 2023-2028
o Exhibit 52: Chart on Ovarian cancer – Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on Ovarian cancer – Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on Ovarian cancer – Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Ovarian cancer – Year-over-year growth 2023-2028 (%)
o 7.4 Breast cancer – Market size and forecast 2023-2028
o Exhibit 56: Chart on Breast cancer – Market size and forecast 2023-2028 ($ million)
o Exhibit 57: Data Table on Breast cancer – Market size and forecast 2023-2028 ($ million)
o Exhibit 58: Chart on Breast cancer – Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Breast cancer – Year-over-year growth 2023-2028 (%)
o 7.5 Others – Market size and forecast 2023-2028
o Exhibit 60: Chart on Others – Market size and forecast 2023-2028 ($ million)
o Exhibit 61: Data Table on Others – Market size and forecast 2023-2028 ($ million)
o Exhibit 62: Chart on Others – Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Others – Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by End-user
o Exhibit 64: Market opportunity by End-user ($ million)
o Exhibit 65: Data Table on Market opportunity by End-user ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2023-2028
o Exhibit 71: Chart on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on North America – Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on North America – Year-over-year growth 2023-2028 (%)
o 9.4 Europe – Market size and forecast 2023-2028
o Exhibit 75: Chart on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Europe – Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Europe – Year-over-year growth 2023-2028 (%)
o 9.5 Asia – Market size and forecast 2023-2028
o Exhibit 79: Chart on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on Asia – Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Asia – Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2023-2028
o Exhibit 83: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o 9.7 US – Market size and forecast 2023-2028
o Exhibit 87: Chart on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on US – Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on US – Year-over-year growth 2023-2028 (%)
o 9.8 UK – Market size and forecast 2023-2028
o Exhibit 91: Chart on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on UK – Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on UK – Year-over-year growth 2023-2028 (%)
o 9.9 Canada – Market size and forecast 2023-2028
o Exhibit 95: Chart on Canada – Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on Canada – Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on Canada – Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Canada – Year-over-year growth 2023-2028 (%)
o 9.10 Germany – Market size and forecast 2023-2028
o Exhibit 99: Chart on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on Germany – Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on Germany – Year-over-year growth 2023-2028 (%)
o 9.11 China – Market size and forecast 2023-2028
o Exhibit 103: Chart on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 104: Data Table on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 105: Chart on China – Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on China – Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ million)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 115: AbbVie Inc. – Overview
o Exhibit 116: AbbVie Inc. – Product / Service
o Exhibit 117: AbbVie Inc. – Key news
o Exhibit 118: AbbVie Inc. – Key offerings
o 12.4 Allarity Therapeutics Inc.
o Exhibit 119: Allarity Therapeutics Inc. – Overview
o Exhibit 120: Allarity Therapeutics Inc. – Product / Service
o Exhibit 121: Allarity Therapeutics Inc. – Key offerings
o 12.5 AstraZeneca Plc
o Exhibit 122: AstraZeneca Plc – Overview
o Exhibit 123: AstraZeneca Plc – Product / Service
o Exhibit 124: AstraZeneca Plc – Key news
o Exhibit 125: AstraZeneca Plc – Key offerings
o 12.6 Bayer AG
o Exhibit 126: Bayer AG – Overview
o Exhibit 127: Bayer AG – Business segments
o Exhibit 128: Bayer AG – Key news
o Exhibit 129: Bayer AG – Key offerings
o Exhibit 130: Bayer AG – Segment focus
o 12.7 BeiGene Ltd.
o Exhibit 131: BeiGene Ltd. – Overview
o Exhibit 132: BeiGene Ltd. – Business segments
o Exhibit 133: BeiGene Ltd. – Key offerings
o Exhibit 134: BeiGene Ltd. – Segment focus
o 12.8 Daiichi Sankyo Co. Ltd.
o Exhibit 135: Daiichi Sankyo Co. Ltd. – Overview
o Exhibit 136: Daiichi Sankyo Co. Ltd. – Product / Service
o Exhibit 137: Daiichi Sankyo Co. Ltd. – Key news
o Exhibit 138: Daiichi Sankyo Co. Ltd. – Key offerings
o 12.9 Everest Pharmaceuticals Ltd.
o Exhibit 139: Everest Pharmaceuticals Ltd. – Overview
o Exhibit 140: Everest Pharmaceuticals Ltd. – Product / Service
o Exhibit 141: Everest Pharmaceuticals Ltd. – Key offerings
o 12.10 GlaxoSmithKline Plc
o Exhibit 142: GlaxoSmithKline Plc – Overview
o Exhibit 143: GlaxoSmithKline Plc – Business segments
o Exhibit 144: GlaxoSmithKline Plc – Key news
o Exhibit 145: GlaxoSmithKline Plc – Key offerings
o Exhibit 146: GlaxoSmithKline Plc – Segment focus
o 12.11 IMPACT Therapeutics
o Exhibit 147: IMPACT Therapeutics – Overview
o Exhibit 148: IMPACT Therapeutics – Product / Service
o Exhibit 149: IMPACT Therapeutics – Key offerings
o 12.12 Jeil Pharmaceuticals Co. Ltd.
o Exhibit 150: Jeil Pharmaceuticals Co. Ltd. – Overview
o Exhibit 151: Jeil Pharmaceuticals Co. Ltd. – Product / Service
o Exhibit 152: Jeil Pharmaceuticals Co. Ltd. – Key offerings
o 12.13 Jiangsu Hengrui Pharmaceuticals Co. Ltd.
o Exhibit 153: Jiangsu Hengrui Pharmaceuticals Co. Ltd. – Overview
o Exhibit 154: Jiangsu Hengrui Pharmaceuticals Co. Ltd. – Product / Service
o Exhibit 155: Jiangsu Hengrui Pharmaceuticals Co. Ltd. – Key offerings
o 12.14 Merck and Co. Inc.
o Exhibit 156: Merck and Co. Inc. – Overview
o Exhibit 157: Merck and Co. Inc. – Business segments
o Exhibit 158: Merck and Co. Inc. – Key news
o Exhibit 159: Merck and Co. Inc. – Key offerings
o Exhibit 160: Merck and Co. Inc. – Segment focus
o 12.15 Ono Pharmaceutical Co. Ltd.
o Exhibit 161: Ono Pharmaceutical Co. Ltd. – Overview
o Exhibit 162: Ono Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 163: Ono Pharmaceutical Co. Ltd. – Key offerings
o 12.16 Pfizer Inc.
o Exhibit 164: Pfizer Inc. – Overview
o Exhibit 165: Pfizer Inc. – Product / Service
o Exhibit 166: Pfizer Inc. – Key news
o Exhibit 167: Pfizer Inc. – Key offerings
o 12.17 Zai Lab Ltd.
o Exhibit 168: Zai Lab Ltd. – Overview
o Exhibit 169: Zai Lab Ltd. – Product / Service
o Exhibit 170: Zai Lab Ltd. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 171: Inclusions checklist
o Exhibit 172: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 173: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 174: Research methodology
o Exhibit 175: Validation techniques employed for market sizing
o Exhibit 176: Information sources
o 13.5 List of abbreviations
o Exhibit 177: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary – Chart on Market Segmentation by End-user
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size – Data Table on global parp (poly adp-ribose polymerase) inhibitors market 2018 – 2022 ($ million)
Exhibits19: Historic Market Size – Distribution Channel Segment 2018 – 2022 ($ million)
Exhibits20: Historic Market Size – End-user Segment 2018 – 2022 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
Exhibits22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
Exhibits23: Five forces analysis – Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants – Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes – Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry – Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition – Five forces 2023 and 2028
Exhibits30: Chart on Distribution Channel – Market share 2023-2028 (%)
Exhibits31: Data Table on Distribution Channel – Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Retail pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Retail pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Retail pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Retail pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Hospital pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Hospital pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Hospital pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Hospital pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Online pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Online pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Online pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Online pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Distribution Channel ($ million)
Exhibits47: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits48: Chart on End-user – Market share 2023-2028 (%)
Exhibits49: Data Table on End-user – Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by End-user
Exhibits51: Data Table on Comparison by End-user
Exhibits52: Chart on Ovarian cancer – Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Ovarian cancer – Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Ovarian cancer – Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Ovarian cancer – Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Breast cancer – Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Breast cancer – Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Breast cancer – Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Breast cancer – Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Others – Market size and forecast 2023-2028 ($ million)
Exhibits61: Data Table on Others – Market size and forecast 2023-2028 ($ million)
Exhibits62: Chart on Others – Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Others – Year-over-year growth 2023-2028 (%)
Exhibits64: Market opportunity by End-user ($ million)
Exhibits65: Data Table on Market opportunity by End-user ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America – Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on North America – Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on North America – Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on North America – Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Europe – Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Europe – Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Asia – Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Asia – Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on US – Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on US – Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on US – Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on US – Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on UK – Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on UK – Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on UK – Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on UK – Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Canada – Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on Canada – Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on Canada – Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Canada – Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on Germany – Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Germany – Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on China – Market size and forecast 2023-2028 ($ million)
Exhibits104: Data Table on China – Market size and forecast 2023-2028 ($ million)
Exhibits105: Chart on China – Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on China – Year-over-year growth 2023-2028 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2023 and 2028
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: AbbVie Inc. – Overview
Exhibits116: AbbVie Inc. – Product / Service
Exhibits117: AbbVie Inc. – Key news
Exhibits118: AbbVie Inc. – Key offerings
Exhibits119: Allarity Therapeutics Inc. – Overview
Exhibits120: Allarity Therapeutics Inc. – Product / Service
Exhibits121: Allarity Therapeutics Inc. – Key offerings
Exhibits122: AstraZeneca Plc – Overview
Exhibits123: AstraZeneca Plc – Product / Service
Exhibits124: AstraZeneca Plc – Key news
Exhibits125: AstraZeneca Plc – Key offerings
Exhibits126: Bayer AG – Overview
Exhibits127: Bayer AG – Business segments
Exhibits128: Bayer AG – Key news
Exhibits129: Bayer AG – Key offerings
Exhibits130: Bayer AG – Segment focus
Exhibits131: BeiGene Ltd. – Overview
Exhibits132: BeiGene Ltd. – Business segments
Exhibits133: BeiGene Ltd. – Key offerings
Exhibits134: BeiGene Ltd. – Segment focus
Exhibits135: Daiichi Sankyo Co. Ltd. – Overview
Exhibits136: Daiichi Sankyo Co. Ltd. – Product / Service
Exhibits137: Daiichi Sankyo Co. Ltd. – Key news
Exhibits138: Daiichi Sankyo Co. Ltd. – Key offerings
Exhibits139: Everest Pharmaceuticals Ltd. – Overview
Exhibits140: Everest Pharmaceuticals Ltd. – Product / Service
Exhibits141: Everest Pharmaceuticals Ltd. – Key offerings
Exhibits142: GlaxoSmithKline Plc – Overview
Exhibits143: GlaxoSmithKline Plc – Business segments
Exhibits144: GlaxoSmithKline Plc – Key news
Exhibits145: GlaxoSmithKline Plc – Key offerings
Exhibits146: GlaxoSmithKline Plc – Segment focus
Exhibits147: IMPACT Therapeutics – Overview
Exhibits148: IMPACT Therapeutics – Product / Service
Exhibits149: IMPACT Therapeutics – Key offerings
Exhibits150: Jeil Pharmaceuticals Co. Ltd. – Overview
Exhibits151: Jeil Pharmaceuticals Co. Ltd. – Product / Service
Exhibits152: Jeil Pharmaceuticals Co. Ltd. – Key offerings
Exhibits153: Jiangsu Hengrui Pharmaceuticals Co. Ltd. – Overview
Exhibits154: Jiangsu Hengrui Pharmaceuticals Co. Ltd. – Product / Service
Exhibits155: Jiangsu Hengrui Pharmaceuticals Co. Ltd. – Key offerings
Exhibits156: Merck and Co. Inc. – Overview
Exhibits157: Merck and Co. Inc. – Business segments
Exhibits158: Merck and Co. Inc. – Key news
Exhibits159: Merck and Co. Inc. – Key offerings
Exhibits160: Merck and Co. Inc. – Segment focus
Exhibits161: Ono Pharmaceutical Co. Ltd. – Overview
Exhibits162: Ono Pharmaceutical Co. Ltd. – Product / Service
Exhibits163: Ono Pharmaceutical Co. Ltd. – Key offerings
Exhibits164: Pfizer Inc. – Overview
Exhibits165: Pfizer Inc. – Product / Service
Exhibits166: Pfizer Inc. – Key news
Exhibits167: Pfizer Inc. – Key offerings
Exhibits168: Zai Lab Ltd. – Overview
Exhibits169: Zai Lab Ltd. – Product / Service
Exhibits170: Zai Lab Ltd. – Key offerings
Exhibits171: Inclusions checklist
Exhibits172: Exclusions checklist
Exhibits173: Currency conversion rates for US$
Exhibits174: Research methodology
Exhibits175: Validation techniques employed for market sizing
Exhibits176: Information sources
Exhibits177: List of abbreviations



★調査レポート[PARP(ポリADPリボースポリメラーゼ)阻害剤のグローバル市場2024-2028:小売薬局、病院薬局、オンライン薬局] (コード:IRTNTR43323-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[PARP(ポリADPリボースポリメラーゼ)阻害剤のグローバル市場2024-2028:小売薬局、病院薬局、オンライン薬局]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆